Stockreport

Pfizer sets sights on R&D strategy amid modest FY25 results [Yahoo! Finance]

Sanofi - American Depositary Shares  (SNY) 
US:NYSE Investor Relations: sanofi.com/en/investors
PDF In FY25, Pfizer generated full-year revenues of $62.6bn. While this meets the company's previously adjusted FY25 profit forecast of $62bn, it represents a 2% operationa [Read more]